Diabetes is caused due to lack of insulin producing ability of the body. Owing to a painful daily routine to administer insulin in the body by pricking the blood vessel every time, there had been a high demand for needle free diabetes care to administer the drug. This eliminates the uncomfortable and painful procedure the patient has to undergo every day. This is likely to drive the demand in the global needle free diabetes care market within the forecast period.
Diabetes needs a daily withdrawing of blood for testing. Thus, constant pricking accelerates the chances of pain and diseases to the patient. As a result, the demand for needle-free diabetes care is expanding fundamentally. Nowadays, glucose monitors and insulin pumps are broadly accessible for automated testing and management of blood glucose levels. Yet, they don’t dispose of the utilization of a needle for skin shots and pricks. In this way, needle-free diabetes care has launched a non-invasive method that is acquiring traction across the world. One of the growth modulators for the development of the global needle free diabetes care market is a surging old-age population with a high predominance of diabetes all over the globe. In addition, rising cases of obesity, changing food habits, and changing lifestyles are also contributing to the market growth.
The global needle free diabetes care market is broadly divided into end-user, application, device, treatment, and region. The device segment is categorized into treatment device and diagnostic device. In terms of end-user, the market is sectioned into diagnostic centers, consumers, hospitals, and clinics. On the basis of treatment, the market is segmented into inhaled insulin, insulin patches, oral insulin, and so on. As per the application, the global market is segregated into insulin delivery, and others.
Geographically, North America is foreseen to register the highest market growth and thus become leading region in the global needle free diabetes care market in the forecast period. This is credited to the rising adoption of new innovations and the rise in the geriatric population across the region. Moreover, the presence of major players is also driving regional growth.
Moreover, due to the rising number of people suffering from diabetes in the Asia Pacific, the region is likely to grab the second position in the global market. The regional governments investing in & funding the research activities along with increased awareness among people are expected to fuel the market demand.
The key players dominating the global needle free diabetes care market include Johnson and Johnson, Inc., Pancreum LLC, Medtronic, Inc., Bioject Medical Technologies, Inc., National Medical Products Inc., Pharmajet, Inc., Glide Pharmaceutical Technologies Ltd., Injex Pharma AG, 3M, Antares Pharma Inc., Zogenix, Inc., MannKind Corporation, Medical International Technology, Inc., European Pharma Group BV, Akra Dermojet, Echo Therapeutics Inc., etc.
Recently, Nemaura Medical launched a wearable that helps track the blood glucose levels of patients. Named as sugarBEAT, a glucose monitoring product is designed for people who are looking for a needle-free solution.